One of the first moves made by the Trump administration was to change the nature of grants made by the National Institutes of Health. Under the new policy, there's a 15% cap on "indirect costs" associated with a given grant. This is money that essentially pays for institutional overhead, not directly related to the new costs of the specific project itself. So how do NIH grants actually work? What are the direct and indirect costs? What is the effect that's already playing out? On this episode, we speak to Carole LaBonne, a biologist and researcher at Northwestern University, on what she's already seeing from the changes.
Read more:
Trump’s Science Agency Pick Says He Won’t Cut More Personnel
The US Is Withdrawing From Global Health at a Dangerous Time
Odd Lots is coming to Washington, DC! Get your tickets for our Jones Act debate here.

Baidu's CFO on How It Became a Full-Stack AI Player
47:31

How Lenovo's CFO Is Allocating Capital During One of History's Biggest Booms
56:12

Rory Johnston on Why His $200 Oil Prediction Didn't Turn Out Right
32:15